Q-Line Biotech Limited
SMEQLINE • NSE
Issue details
Price band
₹326 - ₹343
Lot size
400 shares
Issue size
₹214 Cr
Min. investment
₹1,37,200
Registrar
Purva Sharegistry (India)
Grey market premium
Save your family's PANs once and check allotment for everyone the moment results are out.
Sign in with a mobile OTP. It takes 20 seconds.
IPO Timeline
Open
21 May
Close
25 May
Allotment
26 May
Listing
29 May
- Refunds & demat credit
- 27 May 2026
- Mandate end
- 9 Jun 2026
We calculate these dates from the allotment and close dates, so please treat them as indicative.
Application size
| Category | Minimum | Maximum |
|---|---|---|
| Retail | 400shares 1 lot · ₹1,37,200 | 400shares 1 lot · ₹1,37,200 |
| HNI | 800shares 2 lots · ₹2,74,400 | No limit funds permitting |
Based on the upper price band of ₹343 and a lot of 400 shares.
Issue structure
Face value
₹10 per share
Issue type
Bookbuilding IPO
Sale type
Fresh capital only
Fresh issue
₹204 Cr
59,40,000 shares
Shares pre-issue
1,70,74,999
Shares post-issue
2,33,28,199
Reservation
- QIB
- 29,69,200
- NII
- 8,91,600
- Retail
- 20,79,200
Valuation & ratios
| Metric | Pre-IPO | Post-IPO |
|---|---|---|
| EPS | 16.47 | 22.12 |
| P/E | 20.82 | 15.51 |
| Market cap | ₹585.67 Cr. | ₹1,107.16 Cr |
| KPI | Dec 31, 2025 | Mar 31, 2025 |
|---|---|---|
| ROE | 16.88% | 23.74% |
| ROCE | 13.32% | 17.66% |
| Debt/Equity | 1.06 | 0.87 |
| RoNW | 16.88% | 23.74% |
| PAT Margin | 16.65% | 8.97% |
| EBITDA Margin | 27.64% | 22.73% |
| NAV | 140.81 | 120.60 |
| Price to Book Value | 2.44 | 2.84 |
Financials
| Metric | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Total income | 236.5 | 322.58 | 206.45 | 184.81 |
| Profit after tax | 38.69 | 28.13 | 34.44 | 32.1 |
| EBITDA | 64.23 | 71.32 | 37.63 | 32.98 |
| Net worth | 229.16 | 189.95 | 161.81 | 127.37 |
| Assets | 561.34 | 455.49 | 339.25 | 251.58 |
| Reserves & surplus | 212.89 | 188.37 | 160.24 | 125.79 |
| Total borrowing | 243.85 | 164.95 | 96.91 | 73.65 |
Figures in ₹ crore, as reported by the company in its offer document.
Objects of the issue
- 1.To meet working capital requirements₹93.5 Cr
- 2.Repayment of certain borrowing availed by the Company, in part or full₹90 Cr
- 3.General Corporate Purposes₹5.1 Cr
- 4.Issue Expenses₹25.89 Cr
What the company says it intends to do with the money raised.
Recent comparable IPOs
| Company | Issue price | P/E | Listing close | Listing gain |
|---|---|---|---|---|
| Earkart Ltd.SME | ₹135 | 20.48 | ₹142.25 | +5.37% |
| Galaxy Medicare Ltd.SME | ₹54 | 19.01 | ₹51.30 | -5.00% |
| Fabtech Technologies Ltd.Mainboard | ₹191 | 13.32 | ₹182.40 | -4.50% |
Past listing performance of comparable issues. This is not a forecast: listing gains vary widely and can turn negative.
Issue fundamentals compiled from the company's offer document via Chittorgarh, last read 27 Sep 2026. Always verify against the RHP before applying.